Gómez-Acebo & Pombo advises AMRI on €160m pharma deal

Gómez-Acebo & Pombo and Goodwin Procter advised US-based Albany Molecular Research (AMRI) on the acquisition of Gadea Pharmaceutical Group, a privately-held company located in Valladolid, Spain.

 

The transaction was valued at €160 million, according to Mergermarket data.

The deal involved the issuance of 2.2 million shares of common stock – valued at $43.8 million – to Gadea’s owners, with the balance paid in cash and via the assumption of existing debt.

On a stand-alone basis, Gadea’s forecasted full year 2015 revenue is estimated to be between $80 million and $90 million.

“The acquisition of Gadea marks another milestone in our company’s path towards becoming the preeminent supplier of custom and complex drug development services and product to both the branded and generic pharmaceutical industry,” said William S. Marth, AMRI’s president and chief executive officer.

Gómez-Acebo & Pombo advises AMRI on €160m pharma deal

Ben Cook

iberianlawyer.com

Iberian Lawyer, is a monthly digital magazine, published by LC Publishing, available in Spanish and English. It represents the main source of information in the legal business sector in Spain and Portugal. The digital magazine – and its portal – address to the protagonists of law firms and in-house lawyers. The magazine is available for free on the website and on Google Play and App Store.

In every issue of the magazine, you will find rankings of lawyers, special report on trends, interviews, information about deals and their advisors.

For further information, please visit the Group’s website www.lcpublishinggroup.com

Iberian Lawyer
Registered office: C/ Manuel Silvela, 8 - Oficinas 1 Dcha 28010 Madrid España

Copyright 2022 © All rights Reserved. Design by Origami Creative Studio

SHARE

Share on linkedin
Share on twitter
Share on facebook
Share on whatsapp
Share on email
Share on telegram